Cargando…

Erucic Acid—Both Sides of the Story: A Concise Review on Its Beneficial and Toxic Properties

Erucic acid (EA) is monounsaturated fatty acid (22:1 n-9), synthesized in the seeds of many plants from the Brassicaceae family, with Brassica napus, B. rapa, or B. carinata considered as its richest source. As the compound has been blamed for the poisoning effect in Toxic Oil Syndrome, and some dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Galanty, Agnieszka, Grudzińska, Marta, Paździora, Wojciech, Paśko, Paweł
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962393/
https://www.ncbi.nlm.nih.gov/pubmed/36838911
http://dx.doi.org/10.3390/molecules28041924
_version_ 1784895993499615232
author Galanty, Agnieszka
Grudzińska, Marta
Paździora, Wojciech
Paśko, Paweł
author_facet Galanty, Agnieszka
Grudzińska, Marta
Paździora, Wojciech
Paśko, Paweł
author_sort Galanty, Agnieszka
collection PubMed
description Erucic acid (EA) is monounsaturated fatty acid (22:1 n-9), synthesized in the seeds of many plants from the Brassicaceae family, with Brassica napus, B. rapa, or B. carinata considered as its richest source. As the compound has been blamed for the poisoning effect in Toxic Oil Syndrome, and some data indicated its cardiotoxicity to rats, EA has been for decades classified as toxic substance, the use of which should be avoided. However, the cardiac adverse effects of EA have not been confirmed in humans, and the experiments in animal models had many limitations. Thus, the aim of this review was to present the results of the so far published studies on both toxic, and pharmacological properties of EA, trying to answer the question on its future medicinal use. Despite the ambiguous and relatively small data on toxic and beneficial effects of EA it seems that the compound is worth investigating. Further research should be particularly directed at the verification EA toxicity, more in-depth studies on its neuroprotective and cytotoxic properties, but also its use in combination with other drugs, as well as its role as a drug carrier.
format Online
Article
Text
id pubmed-9962393
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99623932023-02-26 Erucic Acid—Both Sides of the Story: A Concise Review on Its Beneficial and Toxic Properties Galanty, Agnieszka Grudzińska, Marta Paździora, Wojciech Paśko, Paweł Molecules Review Erucic acid (EA) is monounsaturated fatty acid (22:1 n-9), synthesized in the seeds of many plants from the Brassicaceae family, with Brassica napus, B. rapa, or B. carinata considered as its richest source. As the compound has been blamed for the poisoning effect in Toxic Oil Syndrome, and some data indicated its cardiotoxicity to rats, EA has been for decades classified as toxic substance, the use of which should be avoided. However, the cardiac adverse effects of EA have not been confirmed in humans, and the experiments in animal models had many limitations. Thus, the aim of this review was to present the results of the so far published studies on both toxic, and pharmacological properties of EA, trying to answer the question on its future medicinal use. Despite the ambiguous and relatively small data on toxic and beneficial effects of EA it seems that the compound is worth investigating. Further research should be particularly directed at the verification EA toxicity, more in-depth studies on its neuroprotective and cytotoxic properties, but also its use in combination with other drugs, as well as its role as a drug carrier. MDPI 2023-02-17 /pmc/articles/PMC9962393/ /pubmed/36838911 http://dx.doi.org/10.3390/molecules28041924 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Galanty, Agnieszka
Grudzińska, Marta
Paździora, Wojciech
Paśko, Paweł
Erucic Acid—Both Sides of the Story: A Concise Review on Its Beneficial and Toxic Properties
title Erucic Acid—Both Sides of the Story: A Concise Review on Its Beneficial and Toxic Properties
title_full Erucic Acid—Both Sides of the Story: A Concise Review on Its Beneficial and Toxic Properties
title_fullStr Erucic Acid—Both Sides of the Story: A Concise Review on Its Beneficial and Toxic Properties
title_full_unstemmed Erucic Acid—Both Sides of the Story: A Concise Review on Its Beneficial and Toxic Properties
title_short Erucic Acid—Both Sides of the Story: A Concise Review on Its Beneficial and Toxic Properties
title_sort erucic acid—both sides of the story: a concise review on its beneficial and toxic properties
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962393/
https://www.ncbi.nlm.nih.gov/pubmed/36838911
http://dx.doi.org/10.3390/molecules28041924
work_keys_str_mv AT galantyagnieszka erucicacidbothsidesofthestoryaconcisereviewonitsbeneficialandtoxicproperties
AT grudzinskamarta erucicacidbothsidesofthestoryaconcisereviewonitsbeneficialandtoxicproperties
AT pazdziorawojciech erucicacidbothsidesofthestoryaconcisereviewonitsbeneficialandtoxicproperties
AT paskopaweł erucicacidbothsidesofthestoryaconcisereviewonitsbeneficialandtoxicproperties